PT - JOURNAL ARTICLE AU - Limam, Oualid AU - Limam, Mohamed TI - Contribution to COVID-19 spread modelling: A physical phenomenological dissipative formalism AID - 10.1101/2020.05.02.20088971 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.02.20088971 4099 - http://medrxiv.org/content/early/2020/05/08/2020.05.02.20088971.short 4100 - http://medrxiv.org/content/early/2020/05/08/2020.05.02.20088971.full AB - In this study, we propose an evolution law of COVID-19 transmission based first on a representation of population by a domain part of an infinite ordered lattice in which epidemic evolution is represented by a wave like free spread starting from a first case as an epicentre. Free energy of spread on a given day is defined equal to the natural logarithm of the number of infected cases. Dissipation of propagation is obtained using a postulated form of free energy built using thermodynamics of irreversible processes in analogy to isotherm wave propagation in solids and elastic damage behaviour of materials. The proposed expression of daily free energy rate leads to dissipation of propagation introducing a parameter quantifying measures taking by governments to restrict transmission. Entropy daily rate representing disorder produced in the initial system is also explicitly defined. In this context, a simple law of evolution of infected cases as function of time is given in an iterative form. The model predicts different effects on peak of infected cases Imax and epidemic period, including effects of population size N, effects of measures taking to restrict spread, effects of population density and effect of a parameter T similar to absolute temperature in thermodynamics. Different effects are presented first. The model is than applied to epidemic spread in Tunisia and compared with data registered since the report of the first confirmed case on Mar 2, 2020. It is shown that the low epidemic size in Tunisia is essentially due to a low population density and relatively strict restriction measures including lockdown and quarantine.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNational observer for new and emergent diseases, Tunisia